Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves
Top Cited Papers
Open Access
- 7 October 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 37 (28), 2263-2271
- https://doi.org/10.1093/eurheartj/ehv526
Abstract
We sought to evaluate the frequency of early hypo-attenuated leaflet thickening (HALT) of the SAPIEN 3 transcatheter aortic valve (S3). Of 249 patients who had undergone S3 implantation, we studied 156 consecutive patients (85 women, median age 82.2 ± 5.5 years) by electrocardiogram (ECG)-triggered dual-source computed tomography angiography (CTA) after a median of 5 days post-transcatheter aortic valve implantation. The prosthesis was assessed for HALT. Apart from heparin, peri-interventional antithrombotic therapy consisted of single- (aspirin 29%) or dual- (aspirin plus clopidogrel 71%) antiplatelet therapy. Hypo-attenuated leaflet thickening was found in 16 patients [10.3% (95% confidence interval (CI) 5.5–15.0%)] of the patients. None of the baseline and procedural variables were significantly associated with HALT, nor did we find a significant association with the antithrombotic regimen, either peri-interventionally or at the time of CTA. Hypo-attenuated leaflet thickening was found in 6 of 45 patients with peri-interventional single-antiplatelet therapy and in 10 of 111 patients with dual-antiplatelet therapy at the time of intervention [13.3% (95% CI 3.4–23.3%) vs. 9% (95% CI 3.7–14.3%), P = 0.42]. Hypo-attenuated leaflet thickening was not associated with clinical symptoms, but a small, albeit significant difference in mean pressure gradient at the time of CTA (11.6 ± 3.4 vs. 14.9 ± 5.3 mmHg, P = 0.026). Full anticoagulation led to almost complete resolution of HALT in 13 patients with follow-up CTA. Irrespective of the antiplatelet regimen, early HALT occurred in 10% of our patients undergoing transcatheter aortic S3 implantation. Early HALT is clinically inapparent and reversible by full anticoagulation.Keywords
This publication has 33 references indexed in Scilit:
- Revisión sistemática de la trombosis protésica tras implante percutáneo de válvula aórticaRevista Espanola de Cardiologia, 2015
- Transcatheter heart valve failure: a systematic reviewEuropean Heart Journal, 2014
- Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantationEuroIntervention, 2014
- Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiographyEuropean Heart Journal, 2013
- Subacute Transcatheter CoreValve Thrombotic ObstructionCirculation: Cardiovascular Interventions, 2013
- Bioprostheses “Thrombosis” After Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology, 2013
- Reversible Edwards Sapien XT Dysfunction Due to Prosthesis Thrombosis Presenting as Early Structural DeteriorationJournal of the American College of Cardiology, 2012
- Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and BleedingJAMA, 2012
- Diagnosis of obstructive thrombosis in a porcine bioprosthesis in the aortic position by contrast-enhanced ECG-gated computer tomographyEuropean Heart Journal, 2012
- Thrombotic Restenosis After Minimally Invasive Implantation of Aortic Valve StentCirculation, 2009